Rani Therapeutics Holdings (RANI) Return on Invested Capital (2021 - 2023)

Rani Therapeutics Holdings' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.18% for Q4 2023.

• On a quarterly basis, Return on Invested Capital rose 203.0% year-over-year to 0.18% in Q4 2023; TTM through Dec 2023 was 0.18%, a 203.0% increase from a year earlier, with the FY2021 full-year figure at 3.81%, changed N/A from the prior year.
• Return on Invested Capital grew to 0.18% in Q4 2023 per RANI's latest filing, from 1.1% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.09% in Q2 2021 and bottomed at 9.81% in Q2 2023.
• The 3-year median for Return on Invested Capital is 0.23% (2022), against an average of 1.53%.
• Biggest YoY gain for Return on Invested Capital was 203 bps in 2023; the steepest drop was 953 bps in 2023.
• Year by year, Return on Invested Capital stood at 0.12% in 2021, then slumped by 1742 bps to 2.21% in 2022, then surged by 92 bps to 0.18% in 2023.
• Per Business Quant, the three latest RANI Return on Invested Capital figures stand at 0.18% (Q4 2023), 1.1% (Q3 2023), and 9.81% (Q2 2023).